Related Experiment Videos

[Primary lymphoma of the heart: difficulties in diagnosis and treatment]

O V Blagova, A V Nedostup, S L Dzemeshkevich

    Terapevticheskii Arkhiv
    |June 17, 2011
    PubMed

    Insights

    Primary cardiac lymphoma, a rare B-cell non-Hodgkin's lymphoma, presents diagnostic challenges. This case highlights a patient with pre-existing cardiac conditions who developed lymphoma, ultimately succumbing to complications despite chemotherapy.

    Area of Science:

    • Cardiology
    • Oncology
    • Pathology

    Background:

    • Primary cardiac lymphoma is a rare malignancy, accounting for 1.3-2.0% of primary heart tumors.
    • The case involves a 43-year-old male with a history of ventricular tachycardia, AB-block, hypertrophic cardiomyopathy, and pericardial effusion.

    Observation:

    • The patient experienced worsening dyspnea, right ventricular hypertrophy, and elevated cardiac pressures.
    • Imaging revealed a massive tumor in the heart and mediastinum, initially misdiagnosed as sarcoma.
    • Biopsies confirmed diffuse large B-cell lymphoma involving the liver and lymph nodes.

    Findings:

    • The patient underwent pulmonary artery valve balloon angioplasty prior to lymphoma diagnosis.
    • Despite effective chemotherapy (CHOP), the patient developed mesenterial thrombosis and died.

    Implications:

    • This case underscores the diagnostic complexities of primary cardiac lymphoma, especially in patients with pre-existing cardiac conditions.
    • It highlights the critical need for accurate and timely diagnosis and the challenges in managing treatment strategies for this rare disease.

    Related Concept Videos

    Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

    Cardiomyopathy III: Hypertrophic Cardiomyopathy

    Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
    Cardiomyopathy I: Introduction and Classification01:25

    Cardiomyopathy I: Introduction and Classification

    Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
    Heart Failure IV: Classification and Diagnostic Evaluation01:30

    Heart Failure IV: Classification and Diagnostic Evaluation

    Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
    Cardiomyopathy II: Dilated Cardiomyopathy01:30

    Cardiomyopathy II: Dilated Cardiomyopathy

    Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
    Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

    Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

    The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
    Cardiac Catheterization III: Left Heart Catheterization01:24

    Cardiac Catheterization III: Left Heart Catheterization

    Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...